Relationship between hyperglycaemia at admission and prognosis in patients with acute myocardial infarction: a

Linlin Liu1, Jun Qian1, Wenwen Yan1

  • 1Department of Cardiology, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai, China.

Insights

High blood sugar on admission predicts higher mortality in acute myocardial infarction (AMI) patients, particularly those without diabetes. This finding highlights the importance of glucose management in AMI care.

Area of Science:

  • Cardiology
  • Endocrinology
  • Critical Care Medicine

Background:

  • The prognostic significance of admission hyperglycemia in acute myocardial infarction (AMI) remains incompletely understood.
  • Optimal glucose thresholds for risk stratification in AMI patients are not well-defined.

Purpose of the Study:

  • To determine the optimal admission blood glucose thresholds for predicting mortality in AMI patients.
  • To evaluate the impact of hyperglycemia on hospital and 1-year mortality in AMI patients, stratified by diabetes status.

Main Methods:

  • Retrospective analysis of 2027 AMI patients from the MIMIC-III database (June 2001-December 2012).
  • Receiver operating characteristic (ROC) curve analysis to identify significant blood glucose cut-off values (Glucose_0) for predicting hospital mortality.
  • Classification of patients into hyperglycemia and non-hyperglycemia groups based on identified thresholds.

Main Results:

  • Admission hyperglycemia was associated with significantly increased hospital mortality in AMI patients, irrespective of diabetes status.
  • For AMI patients without diabetes, hyperglycemia independently predicted increased 1-year mortality (HR, 1.47; 95% CI 1.18-1.82).
  • The association between hyperglycemia and 1-year mortality was not significant in AMI patients with diabetes (HR, 1.35; 95% CI 0.93-1.95).

Conclusions:

  • Admission hyperglycemia serves as an independent predictor of mortality in patients with AMI.
  • The prognostic impact of admission hyperglycemia is more pronounced in AMI patients without a history of diabetes.
  • These findings underscore the importance of monitoring and managing blood glucose levels in AMI patients for improved clinical outcomes.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
17
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
14
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
306
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
25
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
613
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
36